{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:10:08Z","timestamp":1749759008383,"version":"3.41.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.msard.2025.106454","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T16:26:50Z","timestamp":1744907210000},"page":"106454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical characteristics and outcome of double-AQP4\/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter study"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-4225","authenticated-orcid":false,"given":"Michael","family":"Auer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Hegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Di Pauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Bsteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Zinganell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Berek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Barket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Deisenhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106454_bib0001","first-page":"16","article-title":"Advances in the long-term treatment of neuromyelitis optica spectrum disorder","volume":"1","author":"Anderson","year":"2024","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.msard.2025.106454_bib0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106454_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ncl.2012.09.008","article-title":"Transverse myelitis","volume":"31","author":"Beh","year":"2013","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2025.106454_bib0004","doi-asserted-by":"crossref","first-page":"A395","DOI":"10.1016\/j.autrev.2009.12.007","article-title":"The epidemiology of transverse myelitis","volume":"9","author":"Bhat","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2025.106454_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158978","article-title":"Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study","volume":"11","author":"Bsteh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2025.106454_bib0006","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of Multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.msard.2025.106454_bib0007","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.60.9.1290","article-title":"Idiopathic recurrent transverse myelitis","volume":"60","author":"Kim","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106454_bib0008","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1212\/NXI.0000000000000004","article-title":"Predictors of recurrence following an initial episode of transverse myelitis","volume":"1","author":"Kimbrough","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106454_bib0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","article-title":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). part II: attack therapy and long-term management","volume":"271","author":"K\u00fcmpfel","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106454_bib0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(03)00504-0","article-title":"Spinal-cord MRI in multiple sclerosis","volume":"2","author":"Lycklama","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106454_bib0011","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-020-01773-w","article-title":"Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4\/MOG antibodies","volume":"17","author":"Maillart","year":"2020","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2025.106454_bib0012","article-title":"The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis","volume":"23","author":"Rocchi","year":"2024","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106454_bib0013","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1468-1331.2005.01007.x","article-title":"Relapsing acute transverse myelitis: a specific entity","volume":"12","author":"Seifert","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106454_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106454_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14737175.2023.2195095","article-title":"Current perspectives on the diagnosis and management of acute transverse myelitis","volume":"23","author":"Tisavipat","year":"2023","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.msard.2025.106454_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.msard.2016.03.011","article-title":"Prognostic factors associated with long-term disability and secondary progression in patients with multiple sclerosis","volume":"8","author":"Vasconcelos","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106454_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106454_bib0018","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/13524585231199819","article-title":"Double-negative neuromyelitis optica spectrum disorder","volume":"29","author":"Wu","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106454_bib0019","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00415-023-12041-1","article-title":"Multiple sclerosis in the elderly: a retrospective cohort study","volume":"271","author":"Zinganell","year":"2024","journal-title":"J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:29:18Z","timestamp":1749756558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825001968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":19,"alternative-id":["S2211034825001968"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106454","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and outcome of double-AQP4\/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106454"}}